To study the relative abundance and the changes of both estrogen receptor alpha (ER␣) and ER␤ mRNA before and after ovariectomy in major organs important to the regulation of calcium homeostasis, we compared the degree of mRNA expression of ER␣ to that of ER␤ in rat tissues by performing competitive reverse transcription polymerase chain reaction (RT-PCR) with internal standards. Both ER␣ and ER␤ were highly expressed in the ovary {ER␣[(2.2 ± 0.33) × 10 7 copies/µg of total RNA] > ER␤[(1.2 ± 0.33) × 10 5 copies/µg of total RNA]} as we expected. The bone marrow and renal cortex were very important target organs of estrogen because ER␣ was highly expressed ∼2 × 10 5 copies/µg of total RNA, but marrow cells revealed only a very weak expression of ER␤ [(0.7 ± 0.21) × 10 2 copies/µg of total RNA]. Both ER␣ and ER␤ were expressed in the trabecular bone [(3.2 ± 0.56) × 10 3 copy/µg of RNA] and [(2.8 ± 0.21) × 10 2 copy/µg of RNA], respectively. However, they were not detected in the cortical bone. In the jejunum, the expression of ER␣ was not detectable, while ER␤ was expressed very weakly [(1.1 ± 0.24) × 10 2 copies/µg of total RNA]. The thyroid gland expressed low copy numbers of ER␤ [(6.0 ± 0.23) × 10 2 copies/µg of total RNA], but the parathyroid gland was negative for both ER␣ and ER␤ mRNA. In cultured stromal cells, ER␣ and ER␤ mRNAs were not detected after a 24-h culture; however, the rates of mRNA expression of ER␣ and ER␤ reached ∼10 5 copies/µg of total RNA and ∼10 2 copies/µg of total RNA, respectively, after 9-, 11-, and 13-day cultures. After ovariectomy, the expression of ER␣ mRNA decreased abruptly in the bone marrow and renal cortex, and both ER␣ and ER␤ were barely detected in the trabecular bone. In conclusion, ER␣ might be the main ER in organs important for calcium homeostasis, except in the jejunum. The mRNA expression of ER␣ in the bone marrow and renal cortex decreased abruptly after ovariectomy, which may partially explain why the effect of estrogen deficiency can be amplified and why trabecular bone loss is more predominant than cortical bone loss shortly after surgical or natural menopause
INTRODUCTION
U NTIL RECENTLY, only one type of estrogen receptor (ER) had been identified and the tissue selective effects of estrogen-like molecules have been postulated to involve receptor-associated proteins and/or variations in promoter responsive elements. (1) A novel type of ER (ER␤) was discovered recently and it was found to bind estradiol (E 2 ) with relatively high affinity and to be capable of activating transcription of a reported gene in the presence of this ligand. (2) (3) (4) However, it is still very hard to find major differences between two receptors and the roles of ER␤ in the presence of ER␣ at the same cell. (5) Furthermore, several alternatively spliced ER␤ isoforms have also been reported. (6) Therefore, the presence of these two ERs and their isoforms provided more complexity in understanding the pathophysiology of bone loss after menopause.
Estrogen and selective estrogen receptor modulator (SERM) revealed the selective actions of estrogen in different target tissues. (7, 8) Recently, Pan et al. reported that ovariectomy induced increased bone resorption and an increased number of osteoclasts per millimeter of trabecular bone surface in ER␣ knock-out mice. (9) The ER␣ knockout mice model might reveal some compensatory role of ER␤ in the maintenance of bone mass. Paech et al. showed that antiestrogens, but not 17␤-estradiol, can activate a reporter gene downstream of an AP1 site, when ER␤ interacts with AP1. Both antiestrogens and 17␤-estradiol activated the reporter gene when ER␣ was present instead of ER␤. (10) Their observation suggested that ER␣ and ER␤ could produce opposite effects in some circumstances. Therefore, the existence of two ERs presents another potential source of tissue-specific estrogen regulation. However, the two receptors have strikingly similar properties in most settings, so the roles of ER␤ in the presence of ER␣ in the same cell remain a puzzle. (5) Upon interaction with estrogen, ER undergoes a conformational change permitting the displacement of inhibitory proteins. (11) The receptor then spontaneously dimerizes and acquires the ability to interact with specific DNA responses of target organs. ER␣ and ER␤ can be dimerized in several forms such as ER␣ and ER␣, ER␣ and ER␤, and ER␤ and ER␤. (12) The existence of three forms of homo-or heterodimer suggested that different target tissues might respond differently to estrogens or SERMs according to varying ratios of ER␣ and ER␤. Therefore, it is crucial to know the degree of expression of each ER and the changes of ER expression before and after ovariectomy in organs which are important for the regulation of calcium metabolism, and which might provide some clues to help explain the accelerated bone loss after menopause.
In this study, we compared the degree of mRNA expression of ER␣ with that of ER␤ in each organ and analyzed the changes in their expression 3 weeks after ovariectomy by competitive RT-PCR with 30 bp-deleted internal control mRNA. We found the bone marrow and renal cortex were very important target organs for estrogen and the expression of ER␣ in both organs was undetectable 3 weeks after ovariectomy. ER␤ was also not expressed exclusively in the organs important for regulation of calcium homeostasis, except in the jejunum.
MATERIALS AND METHODS

Materials
Female Sprague-Dawley rats (6-8 weeks old) (Charles River Japan, Co., Tokyo, Japan) were used in this study. Rats were randomly divided into two groups, one ovariectomized (OVX) (n ‫ס‬ 12 rats) the other non-OVX (n ‫ס‬ 6 rats). Three weeks later, half of the OVX and all non-OVX rats were sacrificed by cervical dislocation under light ether anesthesia. The remaining OVX rats were then treated with 17␤-estradiol (30 g/kg) for 1 week and sacrificed by the same procedure. The level of serum E 2 was 21.2 ± 3.5 pg/ml and 3.1 ± 0.74 pg/ml in control and OVX rats, respectively. The increase of body weight in OVX rats was greater than that of controls 4 weeks after ovariectomy (from 210 ± 22 g to 298 ± 26 g vs. from 203 ± 20 g to 270 ± 24 g, respectively).
Cell culture
Bone marrow stromal cells were cultured as described previously. (13) The rats were killed by cervical dislocation, and tibiae were aseptically removed and dissected free of adhering tissues. The bone ends were cut off with scissors and the cavity was flushed with 1 ml of alpha modified essential medium (␣-MEM) by slow injection from one end of the bone using a sterile 26 G needle. The medium with flushed bone marrow was centrifuged at 1400 rpm for 10 minutes. Cell pellets were resuspended in culture medium and layered on the Ficoll/Hypaque (specific gravity 1.077) (Pharmacia Biotech, Uppsala, Sweden). After centrifugation at 1400 rpm for 30 minutes, an enriched bone marrow stromal cell fraction was obtained from the interface of the culture medium and the Ficoll/Hypaque layer. The cells were seeded into a 35 mm tissue culture dish at a density of 4 × 10 5 cells/cm 2 and cultured in ␣-MEM containing 10% FBS, penicillin, and streptomycin (100 U/ml and 100 g/ml, respectively). The medium was changed twice weekly from the second week. When the cells were grown to 80% confluence, they were subcultured using conventional techniques employing 0.01% trypsin and 0.05% EDTA.
Design of oligonucleotide
The oligonucleotide ER␣ forward primer-1:
5ЈAATT-T A A T A C G A C T C A C T A T A G G G A / A A T T C T -
GACAATCGACGCCAG and ER␣ reverse primer-1: 5 Ј CGCTT/GTGCTTCAAC-ATTCTCCCTCCTC/ TGCCCACTTCGTAACACTTGCG were used for the construction of ER␣ standard template DNA. The oligonucleotide ER␣ forward primer-2: 5ЈAATTCTGACAAT-CGACGCCAG (+472 relative to ATG) and the ER␣ reverse primer-2: 5ЈGTGCTTCAACATTCTCCCTCCTC (+794 relative to ATG) were used for amplification of a 344-bp fragment of the rat ER␣ mRNA as previously reported. (14) The oligonucleotide ER␤ forward primer-1: 5ЈAATTTAATACGACTCACTATAGGGA/TTCCCG-GCAGCACCAGTAACC and the ER␤ reverse primer: 5ЈGAGCA/TCCCTCTTTGC-GTTTGGACTA/TCAG-TGTCTCTCTGTTTACAGG were used for the construction of ER␤ internal standard-template DNA. The oligonucleotide ER␤ forward primer-2: 5ЈTTCCCG-GCAGCACCAGTAACC (+38 relative to ATG) and the ER␤ reverse primer-2: 5ЈTCCCTCTTTGCGTTTGGA-CTA (+279 relative to ATG) were used for amplification of a 262-bp fragment of the ER␤ mRNA.
Construction of the standard ER␣ and ER␤ template DNA
Total RNA was extracted from the rat ovary and RT-PCR was performed by the standard method for getting ER␣ and ER␤ template DNA. Figure 1 schematically depicts the principle and steps involved in generating internal standards which were used as competitors for RT-PCR of human ER␣ or ER␤. To prepare internal standard DNAs, RT was done with each forward primer-1 and reverse primer-1 of ER␣ or ER␤ as explained below. The purified RNA (0.3 g) and RNAse free distilled water (2.5 l) were boiled for 4 minutes at 94°C in a 500 l microcentrifuge tube, then chilled on ice for ∼1-2 minutes. After a brief spin, the following reagents were added to the tube: 1 l of random hexamers, 1 l of DTT(100 mM), 4 l of 5× RT buffer, 8 l of dNTP(25 mM), 0.5 l of RNAsin, 1 l of AMV RT. The mixture was incubated at 37°C for 10 minutes, then at 42°C for 45-60 minutes. The reaction was stopped by boiling for 4 minutes at 94°C, then chilled on ice. Thirty-five cycles of PCR were done as explained below. The following reagents were added to a 500 l microcentrifuge tube: 10 l of RTproduct, 2 l of MgCl 2 (25 mM), 4 l of 10× PCR buffer, 1 l of forward primer, 1 l of reverse primer, 0.3 l of Taq polymerase, and 33.7 l of DW. The reaction mixture was pulse centrifuged, and PCR amplification was carried out in a DNA Thermal Cycler (Perkin Elmer Cetus, Norwalk, CT, U.S.A.). The prepared samples were denatured at 95°C for 3 minutes. Each cycle consisted of 1 minute denaturization at 95°C, 2 minutes annealing at 52°C, and 3 minutes at 72°C for enzyme extension. The RT-PCR product was run on an agarose gel, and the DNA band was extracted using a DNA purification kit (Qiagen, Inc., Chatsworth, CA, U.S.A.). The synthesized template DNA had the sequence downstream of the T 7 promotor at the 5Ј end and contained a 30 bp deletion that ended 28 bp (ER␣) or 26 bp (ER␤) from the C-terminal end, respectively.
In vitro transcription for synthesis of internal standard ER␣ or ER␤ mRNA
The extracted DNA was transcribed using T7 RNA polymerase applying the Riboprobe in vitro Transcription System (Promega, Co., Madison, WI, U.S.A.). The RNA concentration was determined by spectrophotometry.
Purification of total RNA
Female Sprague-Dawley rats (6-8 weeks old) were sacrificed by cervical dislocation and tissue was collected. Cancellous bone was surgically collected from the distal metaphysis, and cortical bone was collected from the distal diaphysis. Tissue samples were immediately processed for total RNA isolation. Total RNA of each tissue or cultured marrow stromal cells was extracted by using RNeasy Mini kit (Qiagen). Only RNA samples exhibiting an A260/A280 ratio >1. 6 and showing integrity of the RNA by electrophoresis were used in further experiments. After quantitation, RNA was diluted to 100 ng/l in diethylpyrocarbonate (DEPC) H 2 O for RT-PCR. Before RT-PCR analysis, total RNA was electrophoresed on a 1% formaldehyde agarose gel to check for intact 28S and 18S ribosomal bands. All experiments were approved by this Institute's Animal Care Committee.
Competitive RT-PCR
Competitive RT-PCR was done as explained below. The following reagents were added to a 500 l microcentrifuge: 14.8 l of DW, 3 l of 10× buffer, 3 l of 2 mM dNTP, 3 l of 10 pmol each primer (forward primer 2 and reverse primer 2), 1.5 l of 100 mM DTT, 0.3 l RNAsin, 0.3 l of AMV RT, 0.1 l of Taq polymerase, 3 l (300 ng) of extracted tissue RNA, and 1 l of internal standard mRNA. The mixture was incubated at 42°C for 60 minutes and was stopped by boiling for 5 minutes at 95°C. Thirty-three cycles of PCR were done continuously. Each cycle consisted of 1 minute denaturization at 94°C, 1.5 minutes annealing at 62°C, and 2 minutes extension at 72°C for en- zyme extension. The cycling was followed by a final extension at 72°C for 5 minutes. All samples were added to 1 l 10× loading dye and size was fractionated by electrophoresis in a 3.5% meta-agarose gel. Visualization after ethidium bromide staining (30 minutes in 0.5 g) was performed by Polaroid MP-4 camera (Clifton, NJ, U.S.A.) and the amount of DNA band was analyzed. The RNA was serially diluted from 0 to 10 7 copy/l (0, 10 3 , 10 4 , 10 5 , 10 6 , and 10 7 copy/l, respectively). The RT reaction for ␤-actin was performed at 65°C for 25 minutes followed by a twostep PCR reaction (95°C 10 s, 65°C 20 s) in 2.2 mM MgCl 2 for 33 cycles. (15) Products were visualized by running 10 l of 100 l total reaction volume on a 3.5% metaphoragarose/1× TBE gel for 1.5 h at 100 V. The copy number of internal standard mRNA was calculated as: copies/l = OD 260 × 40͑ngրl͒ × 10 −9 × 6 × 10 23 ր͑standard bp × 660͒
After titration of the copy number of internal standard mRNA, 1 l of mRNA (from 0 to 10 7 copies/l) was added to each tube for the RT-PCR reaction. Products were visualized by running 10 l of 100 l total reaction volume on a 3.5% metaphor-agarose/1× TBE gel for 1.5 h at 100 V. To confirm whether nonvisualized products in 3.5% metaphoragarose gel are not expressed at all, we repeated RT-PCR without any internal standard mRNA several times. The results were expressed as the mean ± SE from six observations.
RESULTS
Construction of standard ER␣ and ER␤ template DNA
ER␣ and ER␤ template DNA were constructed through RT-PCR by using the forward primer-1 designed to have the T7 promotor sequence at the 5Ј end and the reverse primer-1 designed to generate 30 bp (c portion in Fig. 1 ) deletion that ended 28 bp (ER␣) or 26 bp (ER␤) from the C-terminal end, respectively. After quantitation, RNA was diluted to 300 ng/l in DEPC H 2 O for RT-PCR.
RT-PCR of ovarian ER␣ and ER␤
A RT mixture was amplified for 15, 20, 25, 30, 33, or 35 cycles with the specific primers, respectively. After 33 cycles, the rate of amplification decreased gradually and it approached a plateau at 35 cycles (data not shown). Thirtythree cycles were found to be the most appropriate because amplification under those conditions was within the linear range and was also submaximal. All experiments described hereafter employed amplification for 33 cycles. Internal standard cDNA amplifications competed with target cDNA amplification. A 345 bp ER␣ and a 315 bp ER␣-internal standard cDNA were obtained by using both ER␣-forward primer-2 and ER␣-reverse primer-2 (Fig. 2, lane 1) . A 262 bp ER␤ and a 232 bp ER␤-internal standard cDNA were obtained by using both ER␤-forward primer-2 and ER␤-reverse primer-2 (Fig. 2, lane 3) . In addition, RT-PCR using ␤-actin primers was performed on all RNA samples as a control for tube-to-tube variability and differences in the amount of RNA (Fig. 2, lanes 2 and 4) .
Competitive RT-PCR
Compared with ER␤, a significantly high expression of the ER␣ gene was detected in the ovary ( Fig. 3 and Table  1 ). ER␣ was expressed in the ovary [(2.2 ± 0.33) × 10 7 copies/g (RNA), renal cortex [(3.1 ± 0.32) × 10 5 copy/ copies/g of RNA], bone marrow [(2.3 ± 0.24) × 10 5 copies/ g of RNA] and uterus [(3.3 ± 0.43) × 10 3 copies/g of RNA]. ER␤ was expressed in the ovary [(1.2 ± 0.33) × 10 5 copies/g of RNA], thyroid [(6.0 ± 0.23) × 10 2 copies/g of RNA], and jejunum [(1.1 ± 0.24) × 10 2 copies/g of RNA]. After ovariectomy, the expression of ER␣ was undetectable in the bone marrow and it dropped markedly to nearly 1/1000th of the pre-OVX value in the renal cortex ( Fig. 4) . However, we could not see any remarkable change of ER␣ expression in the uterus. In contrast to the change of ER␣ expression, there was no change in the expression of ER␤ in the jejunum or thyroid after ovariectomy. One week after 17␤-estradiol (30 g/kg) treatment, the rates of ER␣ expression in the bone marrow and renal cortex increased by 20-30 times of the pretreatment value. However, we could not find any significant change of ER␤ expression in both organs (data not shown).
Expression of ER in trabecular and cortical bone
The rates of ER␣ and ER␤ mRNA expression were analyzed in trabecular and cortical bone. Trabecular bone was surgically collected from the distal metaphysis, and cortical bone was collected from the distal diaphysis. Both ER␣ and ER␤ were expressed in the trabecular bone [(3.2 ± 0.56) × 10 3 copy/g of RNA] and [(2.8 ± 0.21) × 10 3 copy/g of RNA], respectively. However, they were not detected in the cortical bone. After ovariectomy, both ER␣ and ER␤ were hardly detected in the trabecular bone.
Expression of ER in cultured marrow stromal cells
ER␣ and ER␤ mRNA were not detected after a 24-h bone marrow stromal cell culture; however, the rates of mRNA expression of ER␣ and ER␤ reached ∼10 5 copies/ g of total RNA and ∼10 2 copies/g of total RNA, respec- tively, after 9-, 11-, and 13-day cultures ( Table 2 ). To make certain whether they were not expressed at all after a 24-h culture, we repeated RT-PCR several times without adding any internal standard mRNA.
DISCUSSION
The second estrogen receptor (ER␤) was cloned from a rat prostate cDNA library; however, it has been hard to find major differences between ER␣ and ER␤. (2, 15, 16) The formation of a heterodimeric complex between ER␣ and ER␤, recently observed by Pettersson et al. might constitute a hitherto unrecognized mechanism involved in the tissue type-and cell type-specific effects of estrogens and certain antiestrogens. (17) Therefore, it is crucial to study the degree of expression of each ER and the changes of ER expression before and after ovariectomy in organs involved in the regulation of calcium metabolism to understand the potential physiologic implications of this effect on bone. Since antibodies against ER␤ are not yet available, we studied the expression of ER␣ and ER␤ mRNA in each organ and we also studied the change of expression of both mRNAs in these organs 3 weeks after ovariectomy by competitive RT-PCR. In this study, we showed clearly that there was a relative abundance of ER␣ mRNA expression in the bone marrow and renal cortex, and its expression decreased abruptly after ovariectomy. Our system was quantitative, and it was clear that the relative distribution of both ER subtypes was quite different.
ER␣ and ER␤ were expressed abundantly in the ovary as reported previously. (14, 18) An interesting finding was that bone marrow was one of the important target organs of estrogen; however, the degree of ER␤ expression was much lower than that of ER␣. A previous immunoelectron microscopic study also revealed that most of the electrondense reaction was observed in many mononuclear cells located in the marrow stroma (19) and that some ERpositive cells were situated in the hematopoietic tissue. (18) There was a change of time course in the mRNA expression of both ER␣ and ER␤ in the primary culture of bone marrow stromal cells. Both ER␣ and ER␤ were not detected after a 24-h culture; however, the rates of mRNA expression of ER␣ and ER␤ reached ∼10 5 copies/g of total RNA and ∼10 2 copies/g of total RNA, respectively, after 9-, 11-, and 13-day cultures. Marrow stromal cells, osteoblast and osteoclast precursor cells were mixed up in this culture system. Onoe et al. also reported that there was time course of change in mRNA expression of ER␣ and ER␤ in primary osteoblastic cells during differentiation into mature osteoblasts. (20) Therefore, antiresorptive effects of estrogen could be mediated by indirect effect through binding to ER␣ on bone marrow stromal cells and by the direct effects through binding to both ER␣ and ER␤ on differentiated osteoblast and osteoclast cells. Numbers of pre-B cells changed dramatically and reciprocally in response to estrogen levels in mice, suggesting that normal lymphophoiesis might be under hormonal control. (21) Increased proliferation of osteoclast precursor cells after ovariectomy (22) or clonal expansion of B-cell precursors followed by bone loss after estrogen deficiency in mice, which could be mimicked by repletion of interleukin (IL)-7 in cultured B cell precursors, may possibly be the crucial evidence of our story. (23) ER␣ was expressed in the renal cortex, which is another important organ for regulating calcium homeostasis, and the degree of expression was very high [(2.3 ± 0.24) × 10 5 copies/g of RNA]. However, ER␤ was not expressed at all in contrast to the abundant expression of ER␣. A previous study performed by immunohistochemical technique showed that ER was expressed not in tubular epithelial cells but in interstitial cells, capillaries, arteries, and renal capsules. (24) However, because calcium is reabsorbed through tubular epithelial cells and immunohistochemical technique is not a sensitive method if the rate of expression is low, it is therefore necessary that further studies be undertaken to confirm whether ER␣ is expressed in tubular epithelial cells or not. Parathyroid hormone performs the central role in the regulation of calcium homeostasis in mammals; however, the parathyroid gland was not a target organ of estrogen because both ER␣ and ER␤ were not expressed in this study.
The degree of ER␤ expression was very low in the jejunum [(1.1 ± 0.24)10 2 copies/g of RNA]. However, both receptors were not detected in the duodenum and ileum in our system. ER␣ was not detectable in the jejunum, which differed from other findings. We extracted total RNA from the whole layer of jejunum, not just from the mucosal layer. Therefore, if the total copy number of ER␣ was extremely low, it may not have been detected in our study. However, we could compare the relative abundance of ER␤ to that of ER␣ in the jejunum. Our results also reconfirmed that epithelial cells in the jejunum, which is an important site for calcium absorption, contained ER capable of regulating gene transcription for stimulating intestinal calcium absorption or enhancing the uptake of calcium after treatment of 17␤-estradiol in vitro. (25) The thyroid gland was one of the target organs of estrogen as ER␤, not ER␣, was expressed in low abundance. Given the higher incidence and better prognosis of thyroid cancer in women, there were suggestions that this lesion may be influenced by sex hormones without any supporting evidence about the presence of ER in thyroid cancer. (26) Here we found that ER␤ was expressed in the thyroid gland and its expression was not affected by ovariectomy at all. This may indicate that estrogen regulates the proliferation or differentiation of thy- roid cells or performs some other potential roles providing a better prognosis of thyroid cancer through ER␤. Both ER␣ and ER␤ were expressed in the trabecular bone; however, the rate of ER␤ expression was weak, [(3.2 ± 0.56) × 10 3 copy/g of RNA] and [(0.8 ± 0.21) × 10 2 copy/g of RNA], respectively. Recently, a lack of ER was reported to lead to a failure of growth plate to close, as well as to osteoporosis. (9, 27, 28) These estrogen receptor-alpha knockout (ERKO) human and mice models brought us in agreement with our findings that ER␣ was the main ER in the bone marrow, kidney, and even bone. (27, 28) If ER␤ was expressed sufficiently or as the main ER in these organs, ER␤ should compensate for the lack of ER␣ and bone mass should be preserved in ERKO human and mice. Therefore, it can be further evidence that ER␣ is the main ER in these organs.
The change of ER␣ expression after ovariectomy was interesting. Most receptors are up-regulated after withdrawal of ligands, with some exceptions. (29) The expression of ER␣ in bone marrow was undetectable and its expression in the renal cortex dropped markedly 3 weeks after ovariectomy. Recently, the molecular basis of ER regulation of the IL-6 promotor has been determined. (30) Osteoclast formation was decreased by the inhibition of IL-6, and estrogen withdrawal stimulated the proliferation of hematopoietic osteoclast precursors originating from cells of the granulocyte macrophage colony stimulating unit or macrophage colony stimulating unit lineage. (22) Therefore, the effects of estrogen deficiency in bone marrow should be amplified by the near-complete suppression of ER␣ at the transcription level following ovariectomy, and it explains why bone loss is accelerated just after surgical menopause or the early natural postmenopausal period. Meanwhile, the expression of both receptors in the uterus was low, and we failed to provide data demonstrating the effectiveness of ovariectomy on ER expression in the uterus. We could not explain these results clearly. One plausible explanation might be that the expression of ER was measured in the whole uterus, not in endometrium in this study, and the complete down-regulation of ER after ovariectomy might not be biologically relevant in the uterus. We were unable to observe the changes of ER␤ expression in the jejunum and thyroid gland shortly after ovariectomy. To clarify the biologic significance of such changes of mRNA expression of ER after ovariectomy in different target tissues, further studies about the transcriptional regulation of the ER␣ and ER␤ gene in different tissues should be undertaken. In addition, the long-term changes of the degree of ER expression after ovariectomy should be also studied in various tissues.
In conclusion, ER␣ was the main ER in organs important for calcium homeostasis, except in the jejunum; the bone marrow and renal cortex highly expressing ER␣ were the most important target organs for estrogen; and the expression of ER␣ was undetectable in the bone marrow, and its expression in the renal cortex dropped markedly 3 weeks after ovariectomy. Our findings may partially explain the reason why the rate of bone loss, especially in trabecular bone, is accelerated and the bony effect of estrogen deficiency is amplified after surgical or natural menopause.
